Corina Andresen Email

VP, Clinical Development . SonALAsense

Berkeley, CA

Location

LinkedIn

Current Roles

Employees:
15
Revenue:
$2.3M
About
SonALAsense is a clinical-stage company developing ALA sonodynamic therapy (SDT) as a first-in-class, non-invasive drug-device combination for the treatment of recurrent glioblastoma multiforme (rGBM) and other deadly cancers. SDT utilizes MRI-guided focused ultrasound (the device) in combination with aminolevulinic acid (a drug) to selectively target and kill tumor cells.
SonALAsense Address
1111 Broadway
Berkeley, CA
United States
SonALAsense Email